Article info
Clinical and epidemiological research
Extended report
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification
- Correspondence to Gust Verbruggen, Ghent University Hospital, Rheumatology Department, De Pintelaan 185, BE 9000 Ghent, Belgium; gust.verbruggen{at}ugent.be
Citation
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification
Publication history
- Received January 10, 2011
- Accepted October 6, 2011
- First published November 29, 2011.
Online issue publication
May 07, 2012
Article Versions
- Previous version (29 November 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl